Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Conavi Medical Corp T.TMD

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional... see more

TSX:TMD - Post Discussion

Conavi Medical Corp > TMD Titan Medical merger with Conavi is great news for share
View:
Post by MrBinks on Mar 18, 2024 10:00pm

TMD Titan Medical merger with Conavi is great news for share

Patience has paid off for TMD share holders. The merger details are set to be finalized by July . This stock is expected to start at 0.30 which is triple it's current stock price. https://ir.titanmedicalinc.com/news-events/press-releases/detail/403/titan-announces-merger-agreement-with-conavi

With Conavi’s commercial hybrid imaging technology and anticipated financial resources from the merger and financing, the combined company aims to drive market penetration in the fast-growing field of intravascular imaging for coronary procedures. The deal transforms Titan from an R&D-stage firm into a revenue-generating medtech leader.
Comment by drixneon on Mar 19, 2024 9:39am
This post has been removed in accordance with Community Policy
Comment by Pandora on Oct 08, 2024 5:39pm
A 25 for 1 consolidation suggests a price around $1.25 to $1.50 based on a current 5 cents, maybe 6 cents. The name will change to Conavi and the transaction is expected to close on October 11, 2024 (Friday) so it should open on Monday under the new name and price. What are the views for the new company? Growth from the get go or a slide backwards? Consolidations never seem to have a positive ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities